title: [Rheumatic joint disease in childhood and adolescence].
abstract: Rheumatic joint disease in childhood and adolescence is relatively rare. In the general population, 1 child with juvenile arthritis accounts for 100 adult patients with rheumatoid arthritis. At disease onset 50% of affected children are between 2 and 6 years of age. Symptoms are often subtle and pain is usually not the leading symptom. Early treatment of juvenile arthritis is essential in order to prevent long-term sequelae in affected children. Many children are introduced to a pediatric rheumatologist only with considerable delay. Therapy is based on NSAIDs, intra-articular steroid injections, and immunosuppressive drugs. In severe cases patients are treated with biologics. Physical and occupational therapy are important supportive measures in the treatment.
authors.affiliation: Clementine Kinderhospital, Verein Frankfurter Stiftungskrankenhäuser, Frankfurt am Main. rietschel@ckhf.de
authors.forename: C
authors.initials: C
authors.lastname: Rietschel
authors.forename: K
authors.initials: K
authors.lastname: Latta
mesh_terms: D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D002648:Child; D006801:Humans; D007270:Injections, Intra-Articular; D026741:Physical Therapy Modalities; D012213:Rheumatic Fever / Q000175:diagnosis* / Q000628:therapy*; D013256:Steroids / Q000008:administration & dosage*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D013256:Steroids